Eli Lilly Names Lucas Montarce as New CFO Amid Expansion Efforts
Montarce, a 23-year veteran of the company, takes over as CFO during a pivotal period of significant investment and regulatory scrutiny.
- Lucas Montarce steps into CFO role after 23 years at Eli Lilly.
- Montarce's appointment follows former CFO Anat Ashkenazi's move to Google.
- Eli Lilly invests $5.3 billion to expand manufacturing capacity for key drugs.
- Montarce tasked with navigating regulatory challenges and market pressures.
- Eli Lilly's weight-loss drug, tirzepatide, drives company’s market value.
Fortune 
Benzinga 
CNBC 
